Company Overview

Update
Status:
Acquired by AstraZeneca
Founders:
Jerry Wisler, Michael H. Davidson
Headquarters:
Bedminster, NJ
Funding:
$60.20M
Categories:
Biotechnology, Medical, Pharmaceuticals, See All (4)

Omthera Pharmaceuticals develops therapies for patients with elevated triglyceride levels and increased risk of cardiovascular disease.

Description

Update

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Led by a team of experts with exceptional experience in developing new therapies for lipid disorders, Omthera is dedicated to developing innovative therapies for the millions of patients who have elevated triglyceride levels and increased risk of cardiovascular disease.

Current Team (3)

Update

Board Members and Advisors (3)

Update

Funding Rounds (4) - $60.20M

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    Bedminster, NJ

    USA

Images (1)

Update
  • Aaa8eaf71dc0cd02c77c95c332177b03